CA2703258A1 - Methods and compositions for diagnostic use in cancer patients - Google Patents

Methods and compositions for diagnostic use in cancer patients Download PDF

Info

Publication number
CA2703258A1
CA2703258A1 CA2703258A CA2703258A CA2703258A1 CA 2703258 A1 CA2703258 A1 CA 2703258A1 CA 2703258 A CA2703258 A CA 2703258A CA 2703258 A CA2703258 A CA 2703258A CA 2703258 A1 CA2703258 A1 CA 2703258A1
Authority
CA
Canada
Prior art keywords
patient
genes
cancer
vegf
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2703258A
Other languages
English (en)
French (fr)
Inventor
Daniel S. Chen
Jennifer Le Couter
Thomas D. Wu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2703258A1 publication Critical patent/CA2703258A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA2703258A 2007-11-09 2008-11-05 Methods and compositions for diagnostic use in cancer patients Abandoned CA2703258A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US98688407P 2007-11-09 2007-11-09
US60/986,884 2007-11-09
PCT/US2008/082456 WO2009061800A2 (en) 2007-11-09 2008-11-05 Methods and compositions for diagnostic use in cancer patients

Publications (1)

Publication Number Publication Date
CA2703258A1 true CA2703258A1 (en) 2009-05-14

Family

ID=40342593

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2703258A Abandoned CA2703258A1 (en) 2007-11-09 2008-11-05 Methods and compositions for diagnostic use in cancer patients

Country Status (13)

Country Link
US (2) US20090123930A1 (OSRAM)
EP (1) EP2222874A2 (OSRAM)
JP (1) JP2011502513A (OSRAM)
KR (1) KR20100095571A (OSRAM)
CN (1) CN101910416A (OSRAM)
AU (1) AU2008324782A1 (OSRAM)
BR (1) BRPI0817158A2 (OSRAM)
CA (1) CA2703258A1 (OSRAM)
IL (1) IL205246A0 (OSRAM)
MX (1) MX2010005057A (OSRAM)
RU (1) RU2010123381A (OSRAM)
WO (1) WO2009061800A2 (OSRAM)
ZA (1) ZA201002808B (OSRAM)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201510152RA (en) * 2009-07-13 2016-01-28 Genentech Inc Diagnostic methods and compositions for treatment of cancer
MX2012002909A (es) * 2009-09-17 2012-04-19 Hoffmann La Roche Metodos y composiciones para su uso en diagnostico de pacientes con cancer.
CN103109189A (zh) * 2010-07-19 2013-05-15 霍夫曼-拉罗奇有限公司 鉴定响应抗癌疗法的可能性升高的患者的方法
EP2596359A1 (en) * 2010-07-19 2013-05-29 F.Hoffmann-La Roche Ag Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy
SG10201604497UA (en) * 2011-06-02 2016-07-28 Almac Diagnostics Ltd Molecular Diagnostic Test For Cancer
AU2013207778B2 (en) * 2012-01-13 2017-10-12 Genentech, Inc. Biological markers for identifying patients for treatment with VEGF antagonists
CN104364655A (zh) * 2012-06-26 2015-02-18 霍夫曼-拉罗奇有限公司 贝伐单抗组合疗法用于治疗乳腺癌的血浆生物标志物
CA2893033A1 (en) * 2012-12-03 2014-06-12 Almac Diagnostics Limited Molecular diagnostic test for cancer
WO2015050500A1 (en) 2013-09-17 2015-04-09 Agency For Science, Technology And Research Multigene assay for prognosis of renal cancer
GB201409479D0 (en) * 2014-05-28 2014-07-09 Almac Diagnostics Ltd Molecular diagnostic test for cancer
EP3230498B1 (en) * 2014-12-09 2023-01-18 Merck Sharp & Dohme LLC System and methods for deriving gene signature biomarkers of response to pd-1 antagonists
KR101903522B1 (ko) * 2015-11-25 2018-11-23 한국전자통신연구원 다차원 건강데이터에 대한 유사사례 검색 방법 및 그 장치
US20250155442A1 (en) * 2023-11-09 2025-05-15 Sun Jet Biotechnology Inc. Apolipoprotein a-ii biomarkers for detecting and monitoring cancers

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030027216A1 (en) * 2001-07-02 2003-02-06 Kiernan Urban A. Analysis of proteins from biological fluids using mass spectrometric immunoassay
US8691506B2 (en) * 2005-04-13 2014-04-08 Oncotest Gmbh Gene expression profiles being predictive for the response of tumors to pharmaceutically effective compounds
WO2007123722A2 (en) * 2006-03-31 2007-11-01 Bayer Healthcare Llc Methods for prediction and prognosis of cancer, and monitoring cancer therapy

Also Published As

Publication number Publication date
AU2008324782A1 (en) 2009-05-14
RU2010123381A (ru) 2011-12-20
US20090123930A1 (en) 2009-05-14
KR20100095571A (ko) 2010-08-31
EP2222874A2 (en) 2010-09-01
WO2009061800A3 (en) 2009-07-16
JP2011502513A (ja) 2011-01-27
ZA201002808B (en) 2011-07-27
CN101910416A (zh) 2010-12-08
US20110151468A1 (en) 2011-06-23
IL205246A0 (en) 2010-12-30
MX2010005057A (es) 2010-05-19
WO2009061800A2 (en) 2009-05-14
BRPI0817158A2 (pt) 2015-04-14

Similar Documents

Publication Publication Date Title
EP2382472B1 (en) Methods and compositions for diagnostic use in cancer patients
US20110151468A1 (en) Methods and compositions for diagnostic use in cancer patients
AU2010273585B2 (en) Diagnostic methods and compositions for treatment of cancer
US20100029491A1 (en) Methods and compositions for diagnostic use for tumor treatment
CA2772670A1 (en) Methods and compositions for diagnostics use in cancer patients
US8680041B2 (en) Genetic variations associated with tumors
WO2011153224A2 (en) Diagnostic methods and compositions for treatment of cancer

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20131105